REQUEST A DEMO
Total
USD $0.00
Search more companies

Andora-Pharm Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Clothing Stores
Full name: Andora-Pharm Sp. z o.o. Profile Updated: October 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Andora-Pharm Sp. z o.o. is an enterprise located in Poland, with the main office in Skorzewo. It operates in the Department Stores sector. It was incorporated on December 08, 2009. It currently has a total number of 21 - 50 (2014) employees. The latest financial highlights indicate a net sales revenue increase of 21.45% in 2024. Its’ total assets recorded a growth of 6.91%. The net profit margin of Andora-Pharm Sp. z o.o. decreased by 0.7% in 2024.

Headquarters
Ul. Poznanska 4
Skorzewo; Wielkopolskie; Postal Code: 61-185

Contact Details: Purchase the Andora-Pharm Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Andora-Pharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Andora-Pharm Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Andora-Pharm Sp. z o.o. report to view the information.
Incorporation Date:
December 08, 2009
Ownership Details
Purchase this report to view the information.
92.31%
Company Performance
Financial values in the chart are available after Andora-Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
21.45%
Total operating revenue
21.63%
Operating profit (EBIT)
-24.5%
EBITDA
-24.5%
Net Profit (Loss) for the Period
-25.61%
Total assets
6.91%
Total equity
14.63%
Operating Profit Margin (ROS)
-0.82%
Net Profit Margin
-0.7%
Return on Equity (ROE)
2.52%
Debt to Equity Ratio
-4.37%
Quick Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?